Michael Sheikh - Dec 31, 2021 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role
10%+ Owner
Signature
/s/ Mike Sheikh
Stock symbol
BIXT
Transactions as of
Dec 31, 2021
Transactions value $
-$172,867
Form type
5
Date filed
1/28/2022, 01:17 PM
Previous filing
Jan 18, 2022
Next filing
May 13, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT Common Award $54.7K +228K +2.48% $0.24 9.43M Jan 15, 2021 Direct
transaction BIXT Common Award $214K +1.64M +17.43% $0.13 11.1M Jun 4, 2021 Direct
transaction BIXT Common Gift -$268K -1.87M -16.9% $0.14 9.2M Nov 19, 2021 Direct F1
transaction BIXT Common Gift -$193K -400K -4.35% $0.48 8.8M Nov 19, 2021 By Resources Unlimited LLC
transaction BIXT Common Award $1.2K +600K $0.00* 560K Dec 3, 2021 By NDPD Pharma, Inc.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT Warrants Award $18K +50K $0.36 50K May 2, 2021 Common 50K $2.00 by NDPD Pharma, Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares returned to Company's treasury
F2 The warrant agreement includes provisions for dilutive issuance and cash-less exercise